Trial Profile
Plerixafor and risk of myelodysplastic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2014
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Haematological malignancies; Stem cell mobilisation
- Focus Adverse reactions
- 22 Oct 2014 New trial record